- Home
- MRNA
MRNA
Moderna Inc.
as 10-08-2025 3:59pm EST
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | CAMBRIDGE |
| Market Cap: | 9.8B | IPO Year: | 2018 |
| Target Price: | $42.40 | AVG Volume (30 days): | 12.3M |
| Analyst Decision: | Hold | Number of Analysts: | 17 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -7.53 | EPS Growth: | N/A |
| 52 Week Low/High: | $23.15 - $59.73 | Next Earning Date: | 11-06-2025 |
| Revenue: | $3,078,000,000 | Revenue Growth: | -39.05% |
| Revenue Growth (this year): | -39.49% | Revenue Growth (next year): | 9.75% |
Latest Moderna Inc. News
MRNA Breaking Stock News: Dive into MRNA Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Moderna (MRNA): Assessing Valuation After Recent 12% Share Price Jump and Updated Financials
Yahoo Finance Video
5 days ago
Palantir, AI bubble comments, pharma stocks: Trending Tickers
Zacks
6 days ago
Moderna (MRNA) Beats Stock Market Upswing: What Investors Need to Know
Zacks
6 days ago
Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency?
Zacks
6 days ago
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average
Insider Monkey
7 days ago
Brookline Reaffirms Price Target for Moderna (MRNA) After Strong mRNA-1283 Vaccine Results
Barrons.com
7 days ago
These Stocks Moved the Most Today: Nike, Netflix, Fermi, Moderna, AES, Lithium Americas, Sunrun, Corteva, and More
StockStory
8 days ago
Why Pfizer (PFE) Stock Is Trading Up Today
Compare MRNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRNA Moderna Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.